Tell me angina in all detail with proper understanding with photos medicine mbbs

Reading File

Finding Sources

Searching PubMed

angina pectoris management guidelines

Reading File

Finding Sources

Loading Image

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

Reading File

I now have comprehensive content from Harrison's, Robbins, Goldman-Cecil, and Katzung. Let me compile the definitive MBBS-level angina answer.

Angina Pectoris - Complete MBBS Guide

Sources: Harrison's Principles of Internal Medicine 22E | Robbins & Cotran Pathologic Basis of Disease | Goldman-Cecil Medicine | Katzung's Basic & Clinical Pharmacology 16E

1. Definition

Angina pectoris is paroxysmal, recurrent chest discomfort caused by transient, reversible myocardial ischemia that is insufficient to cause myocyte necrosis. The ischemia triggers release of adenosine, bradykinin, and other metabolites that stimulate sympathetic and vagal afferent nerves, producing the characteristic pain.

The word "angina" means choking/strangling; "pectoris" means chest.
It is the most common clinical expression of myocardial ischemia.
Males make up ~70% of all patients; in those <50 years, the proportion is even greater.

2. Pathophysiology - The Core Concept

The fundamental mechanism is an imbalance between myocardial oxygen demand and supply.

Determinants of Myocardial Oxygen DEMAND

Factor	Effect
Wall stress	Increased by ↑ intraventricular pressure, ↑ ventricular radius (volume), ↓ wall thickness
Heart rate	↑ HR → ↑ O₂ demand
Contractility	↑ Contractility → ↑ O₂ consumption

Hemodynamic determinants of myocardial oxygen consumption - from Katzung's Basic & Clinical Pharmacology

Determinants of Myocardial Oxygen SUPPLY

Coronary blood flow is near zero during systole; perfusion occurs mainly in diastole.
Flow = Aortic diastolic pressure / Coronary vascular resistance.
At tachycardia, diastole shortens - this limits perfusion.
Atherosclerotic plaques reduce luminal area and increase resistance.
Endothelial damage impairs vasodilation (reduced NO synthesis).

Key Rule: Ischemia develops when demand exceeds supply, or when supply falls below the threshold of demand. - Goldman-Cecil Medicine

3. Types of Angina Pectoris

A. Stable (Typical) Angina - Most Common

Caused by chronic fixed atherosclerotic stenosis of coronary arteries
Occurs predictably with exertion, emotional stress, cold, meals, or tachycardia
Does NOT occur at rest in a given patient
Relieved within 2-5 minutes by rest or nitrates
The plaque is stable; no thrombosis occurs

B. Unstable Angina (ACS)

Increasingly frequent chest pain, precipitated by progressively less exertion or occurring at rest
Pain lasts >20 minutes
Caused by plaque disruption + superimposed thrombosis + vasospasm + distal embolization
A medical emergency - harbinger of MI
Most cases show evidence of myocyte injury (troponin may be mildly elevated)
Distinguished from NSTEMI by negative troponin

C. Prinzmetal (Variant) Angina

Uncommon; caused by coronary artery spasm (vasospasm)
Occurs at rest, unrelated to physical activity, heart rate, or blood pressure
Can affect normal or atherosclerotic vessels
ECG shows ST-segment elevation (transient) during attack - opposite of stable angina
Responds promptly to nitrates and calcium channel blockers

"Prinzmetal angina responds promptly to vasodilators such as nitroglycerin and calcium channel blockers." - Robbins & Kumar Basic Pathology

D. Silent Ischemia

Ischemia without pain - particularly common in diabetic neuropathy and the elderly
May manifest as dyspnea, nausea, palpitations, diaphoresis, or fatigue - or no symptoms at all

4. CCS Grading of Angina (Canadian Cardiovascular Society)

Class	Description
I	Angina only with strenuous or prolonged physical activity; ordinary activity does not cause angina
II	Slight limitation of ordinary activity (walking >2 blocks, climbing >1 flight of stairs)
III	Marked limitation; angina with walking 1-2 blocks or climbing 1 flight of stairs
IV	Inability to carry on any activity without angina; angina at rest

Classes I-II = stable (chronic ischemic heart disease)
Classes III-IV = severe/unstable

Source: Goldman-Cecil Medicine

5. Clinical Features (History)

Typical patient: Man >50 years or woman >60 years

Character of pain:

Heaviness, pressure, squeezing, smothering, or choking - rarely described as "sharp"
Located substernal or precordial
Patient places a clenched fist over the sternum = Levine's sign
Crescendo-decrescendo pattern - not most severe at onset
Duration: 2-5 minutes (if >20 min, consider NSTEMI/STEMI)

Radiation:

Left shoulder, down both arms (especially ulnar aspects)
Jaw, teeth, neck, back, interscapular region, epigastrium
Rarely radiates below the umbilicus or above the mandible
Does NOT radiate to the trapezius (that pattern = pericarditis)

Precipitants (increase O₂ demand):

Exercise, hurrying, sexual activity
Emotional stress, anger, fright, frustration
Cold weather (causes coronary vasoconstriction + ↑ afterload)
Heavy meals
Tachyarrhythmias

Relief:

Rest (reduces demand)
Sublingual nitroglycerin within 1-3 minutes

Associated symptoms:

Dyspnea (LV dysfunction during ischemia)
Diaphoresis, nausea (autonomic response)
Nocturnal angina (angina decubitus) - patient awakened at night

6. Risk Factors

Modifiable:

Hypertension, dyslipidemia (high LDL), diabetes mellitus
Smoking, obesity, sedentary lifestyle
Metabolic syndrome

Non-modifiable:

Age (men >45, women >55)
Male sex (women protected during reproductive years by estrogen)
Family history of premature CAD (<55 in male relative, <65 in female)

Additional risk markers: Elevated CRP, coronary artery calcification on CT, increased carotid intimal thickness

7. Investigations

ECG (Electrocardiogram)

Situation	ECG Finding
Resting ECG (stable angina, between episodes)	May be normal OR show Q waves (prior MI), T-wave changes
During angina episode (stable angina)	ST-segment depression (subendocardial ischemia)
During Prinzmetal angina attack	ST-segment elevation (transmural ischemia from spasm)
Exercise stress test	ST depression ≥1 mm at 60-80 ms after J-point = positive

A positive exercise test: 2.5 mm ST depression at 5 METs is highly significant.

Echocardiography

Assesses LV function, wall motion abnormalities (regional hypokinesis during ischemia)
Rules out valvular causes (aortic stenosis can mimic angina)

Stress Testing

Exercise ECG (treadmill) - Bruce protocol
Stress echo or nuclear scintigraphy (Tc-99m sestamibi) - for higher sensitivity/specificity
If unable to exercise: pharmacological stress (adenosine, dobutamine)

Coronary CT Angiography (CTA) / Calcium Scoring

Coronary artery calcification (CAC) score correlates with atherosclerotic burden
CTA: noninvasive anatomical assessment of stenosis severity
Used as adjunctive information but not sole basis for decisions

Cardiac Biomarkers

Troponin I/T: NORMAL in stable angina (ischemia but no necrosis)
Troponin elevation distinguishes NSTEMI from unstable angina

Coronary Angiography (Catheterization) - Gold Standard

Direct visualization of coronary anatomy
Fractional flow reserve (FFR) assesses hemodynamic significance of stenosis
Mandatory before revascularization

8. Pharmacology of Anti-Anginal Drugs

The three classic drug groups work by reducing the oxygen demand/supply mismatch:

A. Organic Nitrates (Nitroglycerin, Isosorbide dinitrate/mononitrate)

Mechanism of Action: Nitrates are converted to nitric oxide (NO) intracellularly (via mitochondrial aldehyde dehydrogenase-2). NO activates guanylyl cyclase → ↑ cGMP → dephosphorylation of myosin light chains → vascular smooth muscle relaxation.

Mechanism of action of nitrates - NO → cGMP → smooth muscle relaxation; showing role of eNOS, guanylyl cyclase, MLCK, and sildenafil interaction (Katzung's Basic & Clinical Pharmacology 16E)

Effects:

Venodilatation (dominant) → ↓ preload → ↓ ventricular volume → ↓ wall stress → ↓ O₂ demand
Arterial dilatation → ↓ afterload
Coronary vasodilation → ↑ supply (especially in variant angina)

Pharmacokinetics:

Sublingual GTN: onset in minutes, duration 15-30 min; avoids first-pass metabolism
Oral bioavailability <10-20% due to heavy hepatic first-pass
Transdermal patches: sustained effect but tolerance develops
Half-life: 2-8 minutes (active metabolites longer)

Tolerance: Develops with continuous use; requires a nitrate-free interval of 8-12 hours daily

ADRs: Headache (vasodilation), reflex tachycardia, hypotension, flushing Contraindication: Concurrent PDE-5 inhibitors (sildenafil, tadalafil) - severe hypotension

Preparations:

Drug	Route	Duration
Nitroglycerin (GTN)	Sublingual, transdermal, IV	15-30 min (SL)
Isosorbide dinitrate	Oral	4-6 hours
Isosorbide mononitrate	Oral	6-10 hours

B. Beta-Adrenoceptor Blockers

Mechanism: Block β₁ receptors → ↓ heart rate, ↓ contractility, ↓ blood pressure → ↓ myocardial O₂ demand. Slowing HR also prolongs diastole → improves coronary filling time.

Drugs: Metoprolol (cardioselective), Atenolol, Bisoprolol, Propranolol (non-selective)

Benefits:

Reduce frequency of anginal episodes
Improve exercise tolerance
Reduce mortality after MI (primary prevention of reinfarction)
Cardioselective agents preferred (less bronchoconstriction)

Contraindications: Severe bradycardia, AV block, decompensated heart failure, asthma, Prinzmetal angina (may worsen vasospasm due to unopposed alpha stimulation)

C. Calcium Channel Blockers (CCBs)

Mechanism: Block L-type Ca²⁺ channels → reduce intracellular Ca²⁺ → reduced smooth muscle and cardiac muscle contraction.

Calcium channel blocker mechanism - blocking Ca²⁺ influx prevents Ca²⁺-calmodulin-MLCK activation, leading to smooth muscle relaxation (Katzung's Basic & Clinical Pharmacology 16E)

Types:

Drug	Class	Selectivity	HR effect
Nifedipine	Dihydropyridine	Vascular > cardiac	↑ HR (reflex)
Amlodipine	Dihydropyridine	Vascular > cardiac	Minimal
Verapamil	Phenylalkylamine	Cardiac > vascular	↓↓ HR
Diltiazem	Benzothiazepine	Balanced	↓ HR

Benefits in Angina:

Coronary vasodilation → ↑ supply
Reduce afterload → ↓ demand
Drug of choice in Prinzmetal angina (stop vasospasm)
Verapamil/diltiazem also reduce HR

ADRs: Peripheral edema (dihydropyridines), bradycardia/heart block (verapamil/diltiazem), constipation (verapamil)

D. Ranolazine (Newer agent)

Blocks the late inward sodium current (late I_Na)
↓ Na⁺ → ↓ Ca²⁺ overload via Na⁺/Ca²⁺ exchanger → less ischemic contracture
Reduces angina without significantly affecting heart rate or BP
Used as add-on therapy when standard agents insufficient
Does NOT reduce mortality

E. Ivabradine

Blocks the HCN (funny current, I_f) channel in the SA node
Pure heart rate reduction without affecting contractility
Used in patients intolerant to beta-blockers

9. Treatment Algorithm

Non-pharmacological (lifestyle modifications)

Smoking cessation
Weight loss, regular aerobic exercise (supervised cardiac rehab)
Dietary modification (Mediterranean diet)
Treatment of diabetes, hypertension, dyslipidemia

Pharmacological - Anti-ischemic

Step 1 (all patients):

Sublingual GTN for acute relief
Beta-blocker (first line for stable angina) - reduces events

Step 2 (if beta-blocker insufficient or contraindicated):

Add long-acting nitrate or CCB
Or switch to CCB (particularly dihydropyridine)

Step 3:

Combination: beta-blocker + long-acting nitrate + CCB
Ranolazine or ivabradine as add-on

Pharmacological - Secondary Prevention (MANDATORY)

Drug	Rationale
Aspirin 75-100 mg daily	Antiplatelet - reduces MI risk
Statin (atorvastatin, rosuvastatin)	Plaque stabilization, LDL ↓, anti-inflammatory
ACE inhibitor/ARB	Reduces cardiac remodeling, beneficial in DM + HTN
Beta-blocker	Post-MI mortality reduction

Revascularization

When to refer:

CCS Class III-IV despite optimal medical therapy
High-risk stress test findings (large territory of ischemia, EF <35%)
Left main disease, 3-vessel disease (CABG preferred)

Options:

PCI (Percutaneous Coronary Intervention): Angioplasty ± stent - for single/double vessel disease
CABG (Coronary Artery Bypass Grafting): For left main, 3-vessel disease, diabetics with multi-vessel disease

2026 Evidence Update: A recent meta-analysis (PMID: 41130952) comparing medical management vs. PCI in stable angina confirms that for symptom relief PCI provides benefit, but for mortality outcomes optimal medical therapy remains competitive - patient selection is key.

10. Differential Diagnosis of Chest Pain

Condition	Key Distinguishing Feature
Angina	Substernal, exertional, relieved by GTN
MI	Angina >20 min, not relieved by GTN, ↑ troponin
GERD/esophageal spasm	Relieved by antacids, postprandial, heartburn
Pericarditis	Sharp, positional, worse lying down, radiates to trapezius, friction rub
Aortic dissection	Tearing, radiates to back, BP difference between arms
Pulmonary embolism	Pleuritic pain, dyspnea, risk factors for DVT
MSK (costochondritis)	Reproducible on palpation, Tietze syndrome
Anxiety/panic	Atypical, young, + psychiatric history

11. Complications of Untreated Angina

Acute MI (plaque rupture + complete occlusion)
Sudden cardiac death (ventricular fibrillation from ischemia)
Heart failure (ischemic cardiomyopathy)
Arrhythmias (PVCs, VT)
Progression to unstable angina / ACS

12. Prognosis

Prognostic determinants (Harrison's 22E):

LV function (EF) - most important single predictor
Extent of coronary artery disease (number of vessels involved)
Severity of ischemia on stress testing
Age, additional risk factors (DM, HTN, dyslipidemia)
Evidence of prior MI
3-vessel disease + LV dysfunction: best treated with CABG
Left main disease: CABG preferred over PCI

Quick Summary Table

Feature	Stable Angina	Unstable Angina	Prinzmetal Angina
Cause	Fixed atherosclerosis	Plaque rupture + thrombus	Coronary vasospasm
Trigger	Exertion	Rest or minimal exertion	Rest (often nocturnal)
Duration	2-5 min	>20 min	Variable
ECG	ST depression	ST depression/T-wave changes	ST elevation
Troponin	Normal	Borderline/elevated (NSTEMI)	Normal
Treatment	GTN + BB + statin	ACS protocol (anticoagulation, PCI)	Nitrates + CCBs
GTN response	Yes	Partial/none	Yes

References:

Harrison's Principles of Internal Medicine, 22nd Edition (2025), McGraw-Hill - Chapter on Stable Angina Pectoris
Robbins & Cotran Pathologic Basis of Disease - Chapter on Ischemic Heart Disease
Robbins & Kumar Basic Pathology - Angina Pectoris
Goldman-Cecil Medicine - Angina Pectoris and Chronic Ischemic Heart Disease; CCS Grading
Katzung's Basic and Clinical Pharmacology, 16th Ed. - Chapter 12: Vasodilators & Treatment of Angina Pectoris
Upreti P et al. (2026) - Medical Management vs PCI in Stable Angina [PMID: 41130952]

This is a shared conversation. Sign in to Orris to start your own chat.